HIGHLIGHTS
- who: Jumpei Temmoku and collaborators from the Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan have published the paper: Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis, in the Journal: PLOS ONE of June/17,/2022
- what: The authors aimed to compare the drug retention rates and safety of abatacept (ABT) and tocilizumab (TCZ) in elderly patients with RA. The results of the study demonstrated that ABT and TCZ have similar clinical responses and drug retention rates in elderly patients in a real-world . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.